Provided by Tiger Fintech (Singapore) Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

22.57
+0.08000.36%
Post-market: 22.570.00000.00%18:59 EST
Volume:690.75K
Turnover:15.62M
Market Cap:1.29B
PE:-9.65
High:23.43
Open:22.47
Low:21.79
Close:22.49
Loading ...

BUZZ-Jefferies looks to Lilly data to reignite interest in obesity stocks

Reuters
·
Yesterday

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

Blockhead
·
03 Mar

Morgan Stanley Keeps Their Buy Rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
03 Mar

Structure Therapeutics Is Maintained at Market Outperform by Citizens Capital Markets

Dow Jones
·
28 Feb

William Blair Initiates Structure Therapeutics at Outperform

MT Newswires Live
·
28 Feb

Structure Therapeutics Initiated at Outperform by William Blair

Dow Jones
·
28 Feb

U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp

Reuters
·
28 Feb

Structure Therapeutics Inc. FY Net Income USD -122.526 Million

THOMSON REUTERS
·
28 Feb

Structure Therapeutics Inc - Expects Cash to Fund Operations Through 2027

THOMSON REUTERS
·
28 Feb

Structure Therapeutics Inc. FY Income From Operations USD -158.228 Million

THOMSON REUTERS
·
28 Feb

Press Release: Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights

Dow Jones
·
28 Feb

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

GlobeNewswire
·
30 Jan

Exicure Acquires GPCR's California Subsidiary, Enters Into Licensing Agreement

MT Newswires Live
·
23 Jan

Exicure announces purchase agreement with GPCR Therapeutics

TIPRANKS
·
23 Jan

Press Release: Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Dow Jones
·
23 Jan

Structure Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Price Target $50

THOMSON REUTERS
·
08 Jan